The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats

European Journal of Pharmacology

Volumn 398, Issue 2, 2000, Pages 239-246

  Watanabe, Kei Ichiro ^a,e   Ashby Jr , Charles R ^b   Katsumori, Hiroshi ^c,e   Minabe, Yoshio ^d,e  

^a UNIVERSITY OF TOKYO   (Japan)

^b ST JOHN'S UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Takamatsu Hospital   (Japan)

^e NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); Hippocampus; Kindling; Seizure

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; GRANISETRON; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2B ANTAGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 3 ANTAGONIST; SKB 200646A; UNCLASSIFIED DRUG;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FOCAL EPILEPSY; HIPPOCAMPUS; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE THRESHOLD;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FLUOROBENZENES; GRANISETRON; HIPPOCAMPUS; INDOLES; LOCOMOTION; MALE; PIPERAZINES; PIPERIDINES; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEIZURES; SEROTONIN ANTAGONISTS; SEVERITY OF ILLNESS INDEX; UREA;

EID: 0034674533     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00258-2     Document Type: Article

References (61)

1. 2C serotonin receptors. Abstr. Soc. Neurosci. 22:1996;2086.
2. 3 receptors in the rat medial prefrontal cortex. Brain Res. 550:1991;161-171.
3. 3 receptors in vitro and in vivo. Eur. J. Pharmacol. 237:1993;299-309.
4. 2C receptor. Nat. Genet. 16:1997;387-390.
5. Browning R.A., Hoffman W.E., Simonton R.L. Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxytryptamine: the role of serotonergic neurons. Ann. N. Y. Acad. Sci. 305:1978;437-456.
6. Cryan J.F., Kelliher P., Kelly J.P., Leonard B.E. Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635. J. Psychopharmacol. 13:1999;278-283.
7. Dailey J.W., Yan Q.-S., Adams-Curtis L.E., Ryu J.R., Ko K.H., Mishra P.K., Jobe J.C. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat. Life Sci. 58:1996;259-266.
8. De La Torre J.C., Kawanaga H.M., Mullan S. Seizure susceptibility after manipulation of brain serotonin. Arch. Int. Pharmacodyn. Ther. 188:1970;293-304.
9. Fletcher A., Forster E.A., Bill D.J., Brown G., Cliffe I.A., Hartley J.E., Jones D.E., McLenachan A., Stanhope K.J., Critchley D.J., Childs K.J., Middlefell V.C., Laufumey L., Corradetti R., Laporte A.M., Gozlan H., Hamon M., Dourish C.T. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav. Brain Res. 73:1996;337-353.
10. 1C receptor antagonist. J. Med. Chem. 36:1993;1104-1107.
11. 2B receptor antagonists with improved affinity, selectivity, and oral activity. J. Med. Chem. 38:1995;2524-2530.
12. Forster E.A., Cliffe I.A., Bill D.J., Dover G.M., Jones D., Reilly Y., Fletcher A. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 28:1995;81-88.
13. 1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats. Br. J. Pharmacol. 119:1996;813-818.
14. Giroud M., Dumas R., Dauvergne M., D'Athis P., Rochette L., Beley A., Bralet J. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of children with febrile convulsions. Epilepsia. 31:1990;178-181.
15. Grace G.M., Corcoran M.E., Skeleton R.W. Kindling with stimulation of dentate gyrus: Part I. Characterization of electrographic and behavioral events. Brain Res. 509:1990;249-256.
16. Hoyer D., Waeber C., Schoeffter P., Palacios J.M., Dravid A. 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;252-258.
17. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Myelcharane E.J., Saxena P.R., Humphrey P.P.A. VII. International union of pharmacology of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
18. Jobe P.C., Picchioni A.L., Chin L. Role of brain 5-hydroxytryptamine in audiogenic seizure in the rat. Life Sci. 13:1973;1-13.
19. + channel, in the model of hippocampus-generating partial seizures in rats. Eur. J. Pharmacolacol. 311:1996;37-44.
20. Katsumori H., Minabe Y., Osawa M., Ashby C.R. Jr. Acute effects of various GABA receptor agonists and glutamate antagonists on focal hippocampal seizures in freely moving rats elicited by low-frequency stimulation. Synapse. 28:1998;103-109.
21. 2A antagonist with a favorable CNS safety profile. J. Pharmacol. Exp. Ther. 277:1996;968-981.
22. 2B/2C receptor antagonist. Br. J. Pharmacol. 111:1994;797-802.
23. Klancnik J.M., Obenaus A., Phillips A.G., Baimbridge K.G. The effects of serotonergic compounds on evoked responses in the dentate gyrus and CA1 region of the hippocampal formation of the rat. Neuropharmacology. 30:1991;1201-1209.
24. Kovacs D.A., Zoll J.G. Seizure inhibition by median raphe nucleus stimulation in rat. Brain Res. 70:1974;165-169.
25. Laird H.E., Jobe P.C. The genetically epilepsy-prone rat. Jobe P.C., Laird H.E. Neurotransmitters and Epilepsy. 1987;57-94 Humana Press, Clifton, NJ.
26. Lazarova M., Bendotti C., Samanin R. Studies on the role of serotonin in different regions of the rat central nervous system on pentylenetetrazol-induced seizures and the effect of di-n-propylacetate. Naunyn Schmiedeberg's Arch. Pharmacol. 322:1983;147.
27. Lazarova M., Bendotti C., Samanin R. Evidence that the dorsal raphe area is involved in the effect of clonidine against pentylenetetrazol-induced seizures in rats. Naunyn Schmiedeberg's Arch. Pharmacol. 325:1984;12-16.
28. Leander J.D. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine and ameltolide (LY201116). Epilepsia. 33:1992;573-576.
29. Löscher W., Czuczwar S.J. Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin in different rodent models of epilepsy. Neurosci. Lett. 60:1985;201-206.
30. 2 receptors. Life Sci. 28:1981;1015-1022.
31. McNamara J.O. Drugs effective in the therapy of the epilepsies. Molinoff P.B., Ruddon R.E. The Pharmacological Basis of Therapeutics. 1996;461-486 McGraw-Hill, New York.
32. Mengod G., Nguyen H., Le H., Waeber C., Lubbert H., Palacios J.M. The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding studies. Neuroscience. 35:1990;577-591.
33. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
34. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain: Part II. Serotonin-1 receptors. Brain Res. 346:1985;205-230.
35. Pazos A., Cortes R., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain: Part II. Serotonin-2 receptors. Brain Res. 346:1985;231-249.
36. 1A receptor in the rat brain: correlation with receptor binding. J. Neurosci. 12:1992;440-453.
37. 2B receptors. Mol. Brain Res. 23:1994;163-178.
38. Pranzatelli M.R., Tate E., Huang Y., Haas R.H., Bodensteiner J., Ashwal S., Franz D. Neuropharmacology of progressive myoclonis epilepsy: response to 5-hydroxy-L-tryptophan. Epilepsia. 36:1995;783-791.
39. Racine R.J. Modification of seizure activity by electrical stimulation: motor seizures. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
40. Racine R., Coscina D.V. Effects of midbrain raphe lesions or systemic p-chlorophenylalanine on the development of kindled seizures in rats. Brain Res. Bull. 4:1979;1-7.
41. Salgado D., Alkadhi K.A. Inhibition of epileptiform activity by serotonin in rat CA1 neurons. Brain Res. 669:1995;176-182.
42. 3 receptor antagonism by BRL 43694 (granisetron). Eur. J. Pharmacol. 159:1989;113-124.
43. 2A receptors in antipsychotic activity. Life Sci. 56:1995;2209-2222.
44. Shaywitz B.A., Cohen D.J., Bowers M.B. Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. Neurology. 25:1975;72-79.
45. 125I]7-amino-8-iodo-ketanserine. Eur. J. Pharmacol. 145:1988;213-216.
46. 125I]7-amino-8-iodo-ketanserine. Eur. J. Pharmacol. 172:1989;99-106.
47. 1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology. 27:1988;707-715.
48. Statnik M.A., Maring-Smith M.-L., Clough R.W., Wang C., Dailey J.W., Jobe P.C., Browning R.A. Effect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats. Life Sci. 59:1996;1763-1771.
49. 2C serotonin receptors. Nature. 374:1995;542-546.
50. Van Wijngaarden I., Tulp M.Th.M., Soudijn W. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 188:1990;301-312.
51. Verma A.K., Gupta G.K., Maheshwari M.C. 5-HIAA in cerebrospinal fluid of patients with status epilepticus. Epilepsia. 25:1984;499-501.
52. Wada Y., Nakamura M., Hasegawa H., Yamaguchi N. Role of serotonin receptor subtype in seizures kindled from the feline hippocampus. Neurosci. Lett. 141:1992;21-24.
53. Wada Y., Nakamura M., Hasegawa H., Yamaguchi N. Microinjection of the serotonin uptake inhibitor fluoxetine elevates hippocampal seizure threshold in rats. Neurosci. Res. Commun. 13:1993;143-148.
54. Wada Y., Nakamura M., Hasegawa H., Yamaguchi N. Effect of serotonin uptake inhibiting antidepressants on hippocampal kindled seizures in cats. Neurosci. Res. Commun. 12:1993;119-124.
55. Wada Y., Nakamura M., Hasegawa H., Yamaguchi N. Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci. Lett. 159:1993;179-182.
56. 3 receptor agonist 1-(m-chlorophenyl)-biguanide in the rat kindling model of epilepsy. Brain Res. 759:1997;313-316.
57. Watanabe K., Minabe Y., Katsumori H., Ashby C.R. Jr., Narita N. Serotonin receptors and rat hippocampal seizures. Soc. Neurosci. Abstr. 23:1997;973.
58. Watanabe K., Minabe Y., Ashby C.R. Jr., Katsumori H. Effect of acute administration of various 5-HT receptor agonists on focal lippocampal seizures in freely moving rats. Eur. J. Pharmacol. 350:1998;181-188.
59. Yan Q.S., Mishra P.K., Burger R.L., Bettendorf A.E., Jobe P.C., Dailey J.W. Evidence that carbamazepine and antiepilepsirine may produce a component of anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J. Pharmacol. Exp. Ther. 261:1992;652-659.
60. Yan Q.S., Jobe P.C., Cheong J.C., Koe K.H., Dailey J.W. Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;149-152.
61. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44:1992;401-458.